TLC President On COVID, Cross-Strait Taiwan Tensions

Trial Flexibility Another Key Issue

A recent survey showed healthcare as the sector US public companies were most concerned about (after semiconductors) amid the ongoing China-US tensions over Taiwan. But how do biotech firms in Taiwan itself view the current situation? Scrip spoke to the president of one of the most innovative and active companies in the sector, amid the island’s imminent reopening to the world after over two long years under pandemic restrictions.

China and US standoff over Taiwan raises risks for health players
RISING TENSIONS OVER TAIWAN HEIGHTEN HEALTH SECTOR RISKS, RECENT SURVEY SHOWS • Source: Shutterstock

As China's military jets regularly fly over the strait between the mainland and Taiwan, and its navy conducts drills encircling the waters off the island, the possible outbreak of a conflict seems to be no longer just a remote scenario but more of a possibility.

Although semiconductors are by far Taiwan’s dominant and strategic industry – it is the major manufacturer and supplier of the...

More from China

More from Focus On Asia

Snapshot Of India’s Pharma Manufacturing Network Amid ‘Trumponomics’

 

Scrip collates data on the global manufacturing network of leading Indian drug makers, the markets serviced and production hubs for active pharmaceutical ingredients. Will ongoing geopolitical tensions and policy shifts have a bearing on some of these down the line?

GSK, Bharat On Shigella Vaccine Phase II Data Timelines, Malaria Vaccine Price Halving

 
• By 

GSK tells Scrip about timelines for data expected from two Phase II trials for its Bharat Biotech-partnered shigella vaccine candidate, which puts it ahead of Limmatech/Valneva. Meanwhile, a global-first malaria vaccine, also partnered with Bharat, sees an over 50% price cut

US Tariff Overhang Weighs on Chinese API Exports

 

Chinese API exports to the US fell by 24% year-on-year to $255m in May, when the US and China called a truce in a previously escalating trade war.